Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00484 | N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate | 663598-85-4 |
| Inquiry | ||
| BADC-00485 | 2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate | |
| 2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate is an outstanding biopharmaceutical compound that exhibits great potential as a powerful antiviral entity against a variety of diseases. Its effectiveness is outstanding in fighting dangerous viral infections such as influenza and herpes viruses. The compound works by preventing the virus from replicating, carefully targeting key enzymes critical to its proliferation. | Inquiry | |
| BADC-00486 | 2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate | 107348-47-0 |
| Inquiry | ||
| BADC-00487 | perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate | 160580-70-1 |
| Inquiry | ||
| BADC-00488 | 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid | 121115-30-8 |
| SPDP-sulfo is a biomedical compound that has demonstrated its ability to combat various diseases. Because of its ability to expertly inhibit the tailor-made enzymes that control the progression of diseases such as cancer and inflammation, it emerges as a potential disease intervention tool. | Inquiry | |
| BADC-00489 | 4-((S)-2-((S)-2-amino-3-methylbutanamido)-5-ureidopentanamido)benzyl 2-(pyridin-2-yldisulfanyl)ethylcarbamate | 1610769-13-5 |
| PDP-C1-Ph-Val-Cit is a small molecule compound. It blocks specific enzymes involved in harmful processes of tumor expansion and metastasis, effectively inhibiting cancer progression. | Inquiry | |
| BADC-00490 | Boc-Phe-(Alloc)Lys-PAB-PNP | 1160844-44-9 |
| Boc-Phe-(Alloc)Lys-PAB-PNP is a complex biomedical compound being investigated as an innovative treatment for a variety of diseases, especially cancer. Known for its powerful properties, it effectively halts tumor progression through targeted neutralization of unique enzymes and pathways. | Inquiry | |
| BADC-00491 | Cbz-Phe-(Alloc)Lys-PAB-PNP | 159857-90-6 |
| Cbz-Phe-(Alloc)Lys-PAB-PNP is an important biomedical chemical product that has emerged as a potential therapeutic agent against various diseases. It has demonstrated outstanding capabilities as a candidate compound for targeted therapy against various malignancies, including breast and prostate cancer. This revolutionary compound, Cbz-Phe-(Alloc)Lys-PAB-PNP, utilizes its unique molecular structure to produce profound inhibitory effects on the proliferation of malignant cells. | Inquiry | |
| BADC-00492 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | 253863-34-2 |
| Inquiry | ||
| BADC-00493 | Fmoc-Ala-Ala-Asn-PAB-PNP | 1834516-06-1 |
| Fmoc-Ala-Ala-Asn-PAB-PNP is an excellent and highly discriminating inhibitor widely used in biomedicine for multiple purposes. It is widely used in the field of drug development, especially in the targeted detection and attenuation of malignancies and cancers. | Inquiry | |
| BADC-00494 | Ala-Ala-Asn-PAB | 2149584-00-7 |
| Ala-Ala-Asn-PAB is a peptide derivative widely used in biomedical fields. The product is known for its superior chemical properties, which are highly advantageous in targeted drug delivery and enhanced therapeutic efficacy. Its broad applications include drug research for a variety of diseases, especially cancer. | Inquiry | |
| BADC-00495 | Fmoc-Phe-Lys(Trt)-PAB-PNP | 1116086-09-9 |
| Inquiry | ||
| BADC-00496 | succimimidyl-4-azidobutyrate | 943858-70-6 |
| Succimimidyl-4-azidobutyrate is a superior biopharmaceutical formulation that can facilitate breakthrough drug development and research efforts. As a chemically mediated linker, it accelerates the synthesis of targeted drugs, ultimately resulting in good precision in drug delivery and modulated drug release. | Inquiry | |
| BADC-00497 | sulfo-LC-SPDP | 150244-18-1 |
| Inquiry | ||
| BADC-00498 | Propargyl-NHS Ester | 1174157-65-3 |
| Propargyl-NHS ester is an indispensable small molecule tool in the biomedical field and is a key coupling agent that promotes bioconjugation reactions. This compound labels a range of biomolecules including proteins and peptides, facilitating their unambiguous identification and meticulous monitoring. With its sheer versatility, Propargyl-NHS Ester coordinates a range of tasks, including drug delivery systems, diagnostics and targeted therapies. | Inquiry | |
| BADC-00499 | Mal-PEG6-NHS ester | 1599472-25-9 |
| Mal-PEG6-NHS ester is a non-cleavable ADC linker containing the Maleimide group, 6-unit PEG, and NHS ester. | Inquiry | |
| BADC-01935 | Methyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride | 114676-59-4 |
| Methyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-00505 | 6-Maleimidocaproic acid sulfo-NHS | 103848-61-9 |
| 6-Maleimidocaproic acid sulfo-NHS is a small molecule reagent used in the biomedical industry. It is commonly used to modify biomolecules, such as proteins and antibodies, for site-specific conjugation. This compound enables the efficient and stable attachment of drugs, tags, or targeting moieties to these biomolecules, thereby facilitating the development of innovative treatments for a variety of diseases, including cancer and autoimmune diseases. | Inquiry | |
| BADC-01943 | FMOC-L-HYP(BOM)-OH | 187223-15-0 |
| Fmoc-Hyp(Bom)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00981 | t-Boc-N-amido-PEG2-bromide | 165963-71-3 |
| t-Boc-N-amido-PEG2-bromide is a PEG linker containing a bromide group and a Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The Boc group can be deprotected under mild acidic conditions to form the free amine. | Inquiry |
